UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Evercore
EVR
$12.4B
| $1.72M | ﹤0.01% |
38,844
-21,718
| -36% | -$1.08M |
|
|
LNCE
1352
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.72M | ﹤0.01% |
50,645
+3,300
| +7% | +$104K |
|
|
SF
1353
Stifel
SF
$12.8B
| $1.71M | ﹤0.01% |
122,510
+16,951
| +16% | +$252K |
|
1354
Bruker
BRKR
$7.92B
| $1.71M | ﹤0.01% |
75,243
-282,801
| -79% | -$7.55M |
|
1355
Wendy's
WEN
$1.48B
| $1.71M | ﹤0.01% |
177,882
-776,610
| -81% | -$8.15M |
|
1356
Armstrong World Industries
AWI
$7.84B
| $1.7M | ﹤0.01% |
43,514
+2,104
| +5% | +$86.3K |
|
1357
Vanguard FTSE Developed Markets ETF
VEA
$235B
| $1.7M | ﹤0.01% |
48,034
+3,980
| +9% | +$144K |
|
1358
Belden
BDC
$5.02B
| $1.7M | ﹤0.01% |
28,114
+48
| +0.2% | +$3K |
|
|
MBFI
1359
DELISTED
MB Financial Corp
MBFI
| $1.69M | ﹤0.01% |
46,656
+1,220
| +3% | +$42.1K |
|
1360
Bloomin' Brands
BLMN
$1.03B
| $1.69M | ﹤0.01% |
94,422
| – | – |
|
|
QUNR
1361
DELISTED
Qunar Cayman Islands Limited
QUNR
| $1.68M | ﹤0.01% |
56,500
+26,600
| +89% | +$951K |
|
1362
Littelfuse
LFUS
$11.9B
| $1.67M | ﹤0.01% |
14,142
+379
| +3% | +$44.1K |
|
1363
Zurn Elkay Water Solutions
ZWS
$8.78B
| $1.67M | ﹤0.01% |
176,215
+3,400
| +2% | +$34.2K |
|
|
MGLN
1364
DELISTED
Magellan Health Services, Inc.
MGLN
| $1.67M | ﹤0.01% |
25,317
| – | – |
|
|
FSP
1365
Franklin Street Properties
FSP
$48M
| $1.66M | ﹤0.01% |
135,000
| – | – |
|
1366
Nektar Therapeutics
NKTR
$2.47B
| $1.65M | ﹤0.01% |
7,742
-1,076
| -12% | -$241K |
|
|
MDSO
1367
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.64M | ﹤0.01% |
34,931
+2,289
| +7% | +$99.7K |
|
1368
Monolithic Power Systems
MPWR
$64.9B
| $1.63M | ﹤0.01% |
23,863
| – | – |
|
|
MIK
1369
DELISTED
Michaels Stores, Inc
MIK
| $1.63M | ﹤0.01% |
57,195
-827
| -1% | -$23.4K |
|
|
COHR
1370
DELISTED
Coherent Inc
COHR
| $1.62M | ﹤0.01% |
17,647
-1,778
| -9% | -$164K |
|
|
QLTB
1371
DELISTED
ISHARES BAA BA RATED CORP BOND FUND
QLTB
| – | – |
0
| – | – |
|
|
LGF
1372
DELISTED
Lions Gate Entertainment
LGF
| $1.61M | ﹤0.01% |
79,724
+14,135
| +22% | +$297K |
|
|
MRC
1373
DELISTED
MRC Global
MRC
| $1.61M | ﹤0.01% |
113,160
+4,667
| +4% | +$64.7K |
|
|
CVG
1374
DELISTED
Convergys
CVG
| $1.61M | ﹤0.01% |
64,284
+4,610
| +8% | +$124K |
|
1375
United Bankshares
UBSI
$6.7B
| $1.61M | ﹤0.01% |
42,808
+588
| +1% | +$22.2K |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.